11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Source Url: https://www.jdsupra.com/legalnews/covid-19-report-for-life-sciences-and-24214/
Related
The Chamber of Commerce and employer organizations convinced a federal court judge in California to ...
Read More >
The South Carolina Department of Revenue has released the 2020 county tier rankings for all South Ca...
Read More >
This update is designed to highlight selected important M&A, corporate and commercial court decision...
Read More >
A unionized employer must bargain with its employees’ union before making any unilateral changes in...
Read More >
On January 6, 2020, the New Jersey Department of Labor and Workforce Development (the “Department”...
Read More >
The California Supreme Court has handed down yet another decision broadening the scope of what is co...
Read More >